Skip to content

PTSD: all studies

Page 181 of 210: studies 1,801 to 1,810 of 2,096, newest first. Back to the PTSD overview

Research

410: POSITIVE TRANSFORMATIONAL EXPERIENCE AFTER CRITICAL ILLNESS: AN EXPLORATORY STUDY

Critical Care Medicine 2020 Sam Parnia, Tara Keshavarz, M. M. Mullin

Introduction/Hypothesis: While many intensive care unit survivors report negative long-term psychological outcomes including post-traumatic stress disorder (PTSD), depression, and anxiety, some report a positive transformational outcome associated with the recall of a unique cognitive experience, often referred to using the poorly defined term of near-death experiences (NDE). This aspect of ICU...

MDMA – hopes and fears associated with therapeutic use in mental disorders

Pharmacotherapy in Psychiatry and Neurology 2020 Kamil Kozera, Lena Cichoń, Krzysztof M. Wilczyński et al.

MDMA (3,4-methylenedioxymethamphetamine) is a psychoactive substance classified as a hallucinogen. MDMA acts in the brain through a variety of neurochemical mechanisms, reducing anxiety, giving a sense of oneness with other people, expanding empathy, sharpening the senses and intensifying the experience of emotions. Therefore, the use of the MDMA assisted psychotherapy is being considered in...

Dispositional Mindfulness and Past-Negative Time Perspective: The Differential Mediation Effects of Resilience and Inner Peace in Meditators and Non-Meditators.

Psychology Research and Behavior Management 2020 Jingjing Ge, Jingjing Yang, Jingjing Song et al.

Past-negative time perspective (PNTP) can affect our everyday lives and is associated with negative emotions, unhealthy behaviors, rumination, anxiety, depression, and post-traumatic stress disorder (PTSD). Dispositional mindfulness may be able to reduce the negative effects of PNTP; however, few studies have investigated their relationship. Thus, the purpose of this study was to explore the...

DOI: 10.2147/prbm.s229705 (opens in new tab) Full text (opens in new tab) Meditation Inner peace Past-negative time perspective Psychological intervention +2

Clinical Correlates of Dream Enactment Behaviors in Previously Deployed OEF/OIF/OND Veterans: An Exploratory Analysis.

The Journal of Neuropsychiatry and Clinical Neurosciences 2020 Melissa B Jones, Sangeeth Jeevan, Jingyan Wang et al.

Veterans with posttraumatic stress disorder (PTSD) frequently report dream enactment behavior (DEB). Although DEBs are associated with PTSD symptoms, their relationship with other sleep disorders, including REM behavior disorder, warrants reexamination of their clinical correlates. The investigators used a cross-sectional, exploratory analysis to compare demographic and clinical characteristics...

Safety pharmacology and pharmacogenetics of 3,4-methylenedioxymethamphetamine (MDMA)

edoc (University of Basel) 2020 Patrick Vizeli

Psychoactive substances such as the ring substituted phenylethylamine 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) are widely used in recreational settings. Additionally, recent research highlights substance-assisted psychotherapy as potential new effective treatment for various psychiatric disorders, e.g. post-traumatic stress disorder (PTSD). MDMA releases and inhibits the uptake of...

Characteristics of Adolescents Affected by Mass Psychogenic Illness Outbreaks in Schools in Nepal: A Case-Control Study.

Frontiers in Psychiatry 2020 Ram P Sapkota, Alain Brunet, Laurence J. Kirmayer 21 citations

This paper presents the first systematic case-control study of correlates of mass psychogenic illness (MPI) in an adolescent school population. MPI is generally construed as a dissociative phenomenon spread by social contagion to individuals who are prone to dissociation. We sought to test if the correlates of dissociative experiences most commonly proposed in the literature could predict...

DOI: 10.3389/fpsyt.2020.493094 (opens in new tab) Full text (opens in new tab) Nepal Childhood trauma Dissociation Emotional contagion +3

Mapping Psilocybin-Assisted Therapies: A Scoping Review

medRxiv December 12, 2019 Ron Shore, Paul Ioudovski, Craig Goldie et al. 8 citations preprint

Abstract We conducted a scoping review on psilocybin-assisted therapy for addiction, depression, anxiety and post-traumatic stress disorder. Psilocybin is a naturally-occurring tryptophan derivative found in species of mushroom with psycho-active properties. From 2022 records identified by database searching, 40 publications were included in the qualitative synthesis from which we identified 9...

The Acute Toxic and Neurotoxic Effects of 3,4-methylenedioxymethamphetamine are More Pronounced in Adolescent than Adult Mice

Behavioural Brain Research December 3, 2019 N. Chitre, M. Bagwell, Kevin S. Murnane

3,4-methylenedioxymethamphetamine (MDMA) recently achieved breakthrough status from the Food and Drug Administration (FDA) for post-traumatic stress disorder (PTSD). However, evidence indicates that exposure to toxic doses of 3,4-methylenedioxymethamphetamine (MDMA) can lead to long-lasting dysregulation of brain monoaminergic neurotransmitters, primarily from studies conducted in young adult...

A pilot randomized controlled trial of cognitive behavioral treatment for trauma-related nightmares in active duty military personnel.

Journal of Clinical Sleep Medicine November 26, 2019 Kristi E. Pruiksma, Daniel J. Taylor, Jim Mintz et al.

Study objectives: The aim of this study was to obtain preliminary data on the efficacy, credibility, and acceptability of Exposure, relaxation, and rescripting therapy for military service members and veterans (ERRT-M) in active duty military personnel with trauma-related nightmares. Methods: Forty participants were randomized to either 5 sessions of ERRT-M or 5 weeks of minimal contact control...

DOI: 10.5664/jcsm.8116 (opens in new tab) Full text (opens in new tab) Humans Treatment outcome Pilot projects Dreams +7

WHAT KIND OF HEALING DOES PSYCHEDELIC-ASSISTED PSYCHOTHERAPY FOSTER?

PEOPLE: International Journal of Social Sciences November 15, 2019 Candice L Shelby

World-wide, researchers and practitioners in psychiatry are increasingly interested in the effectiveness of such substances as MDMA, LSA, and psylocibin in treating such disorders as addiction, post-traumatic stress disorder, and other types of depressive and anxiety. Although most of these substances were declared illegal in most countries during the 1970s, research into their use was...